Welcome to our dedicated page for Lument Finance Trust SEC filings (Ticker: LFT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Lument Finance Trust, Inc.'s SEC filings document the governance, capital structure and financing activity of a Maryland commercial real estate debt investor. Its records identify listed common stock and 7.875% Series A Cumulative Redeemable Preferred Stock, and include definitive proxy materials covering annual meeting procedures, director elections, shareholder voting matters and board oversight.
Recent 8-K filings report quarterly and annual results, supplemental financial information, dividend disclosures, material definitive agreements and portfolio-financing transactions. The filing record includes disclosures on commercial real estate collateralized loan obligations, repurchase financing for commercial mortgage loan debt, credit and guaranty agreement amendments, subsidiary-level arrangements and transactions involving affiliates of the company's external manager.
Lument Finance Trust, Inc. (LFT) director William A. Houlihan reported purchasing common stock in an open-market or private transaction. On 2026-08-18, he bought 20,000 shares at $0.60 per share, bringing his directly held position to 300,732 shares after the transaction. The filing’s Rule 10b5-1 checkbox was not marked as being pursuant to a trading plan.
Lument Finance Trust, Inc. reported second-quarter 2026 results and approved a 1-for-10 reverse stock split of its common stock. GAAP net loss attributable to common stockholders was $9.2 million, or $0.18 per share, and Distributable Loss was $5.3 million, or $0.10 per share.
The board declared a $0.04 cash dividend per common share and a $0.49219 dividend per Series A preferred share. Book value per common share was $2.76 as of June 30, 2026. The company held a $1.0 billion floating-rate CRE loan portfolio, 91.7% collateralized by multifamily assets, and a leverage ratio of 4.4x.
The reverse stock split, intended to regain NYSE listing compliance and support an efficient trading market, is expected to become effective at 5:00 p.m. ET on September 9, 2026. It is expected to reduce issued and outstanding common shares from approximately 52.5 million to 5.3 million, with fractional shares paid in cash and percentage ownership otherwise unchanged.
Lument Finance Trust, Inc. reported weaker results for the quarter and six months ended June 30, 2026. For the quarter, it recorded a net loss attributable to common stockholders of $9.2 million versus income of $2.5 million a year earlier, driven largely by a higher provision for credit losses of $8.6 million and increased operating expenses. Basic and diluted EPS fell to $(0.18) from $0.05, while quarterly common dividends were reduced to $0.04 per share from $0.06.
For the first half of 2026, net loss attributable to common stockholders was $10.2 million compared with income of $0.8 million in the prior-year period, and EPS declined to $(0.19) from $0.02. Net interest income for the six months decreased to $10.2 million from $14.7 million as interest expense on secured financings rose. The commercial mortgage loan portfolio’s unpaid principal balance fell to $1.01 billion, with an allowance for credit losses of $21.2 million and $98.1 million of default‑risk loans.
Total assets declined to $1.12 billion from $1.22 billion at year‑end 2025, while total stockholders’ equity decreased to $204.7 million. The company reduced securitized debt obligations to $580.7 million and increased secured financing agreements to $271.1 million. Cash, cash equivalents and restricted cash rose to $54.7 million, supported by strong net cash provided by investing activities, including significant loan principal repayments and REO sale proceeds.
Lument Finance Trust, Inc. reported that on July 24, 2026 it received a deficiency notice from the New York Stock Exchange because the average closing price of its common stock was below $1.00 over a consecutive 30 trading-day period, triggering Section 802.01C of the NYSE Listed Company Manual. The notice does not constitute delisting and the stock continues to trade on the NYSE, subject to compliance with other continued listing standards.
The company has a six-month cure period, ending January 24, 2027, during which it can regain compliance if on the last trading day of any calendar month its common stock closes at or above $1.00 and has a 30 trading-day average at or above that level. Management is monitoring the share price and is considering alternatives, including a potential reverse stock split, though no specific action has been approved.
Lument Finance Trust, Inc. held its annual stockholder meeting on June 10, 2026 and confirmed its current board, executive pay program and auditor. Six directors were re-elected, an advisory vote approved compensation for named executives, and KPMG LLP was ratified as independent auditor for 2026.
The company also declared a quarterly cash dividend of $0.04 per share on its common stock for the second quarter of 2026, payable July 15, 2026 to stockholders of record on June 30, 2026. In addition, it declared a cash dividend of $0.4921875 per share on its 7.875% Series A Cumulative Redeemable Preferred Stock, payable July 15, 2026 to preferred stockholders of record on July 1, 2026.
Lument Finance Trust director Keenan Walter C received a stock grant as part of his board compensation. On this Form 4, he was awarded 12,222 shares of common stock at a value of $1.125 per share, with the footnote clarifying these were director fees paid in stock.
After this award, he directly owns 219,376 shares of Lument Finance Trust common stock. This is a compensation-related acquisition, not an open-market purchase, and reflects routine director fee payment in equity.
Cummins Neil A. reported acquisition or exercise transactions in this Form 4 filing.
Lument Finance Trust director Neil A. Cummins received a stock grant of 12,222 shares of Common Stock as director fees paid in stock at $1.125 per share. This award increased his direct ownership to 127,701 shares following the transaction.
Lument Finance Trust director James Christopher Hunt received 22,222 shares of common stock as director fees paid in stock. The shares were granted at a price of $1.125 per share, reflecting compensation rather than an open-market purchase or sale.
After this stock grant, Hunt directly holds 709,978 shares of Lument Finance Trust common stock. The filing shows no related option exercises or derivative positions, indicating this was a routine equity compensation award for board service.
Lument Finance Trust, Inc. director William A. Houlihan bought additional common stock in two recent open-market transactions. He purchased 10,000 shares on May 20, 2026 at $1.14 per share and another 10,000 shares on May 21, 2026 at $1.19 per share, for a total of 20,000 shares. Following these buys, he directly owns 280,732 common shares.
Lument Finance Trust, Inc. reported first quarter 2026 results with a GAAP net loss attributable to common stockholders of $1.0 million, or $(0.02) per share. After adjustments, Distributable Earnings were $1.1 million, also $0.02 per share, reflecting core cash earnings.
The board declared a quarterly common dividend of $0.04 per share and a preferred dividend of $0.49219 per Series A preferred share. Book value per common share was $2.97 as of March 31, 2026, modestly below prior quarters. The company held a $1.1 billion floating-rate commercial real estate loan portfolio, about 92.6% backed by multifamily assets, with 91.8% of loans performing and a weighted average risk rating of 3.1.